Table 1.
Day | BPE | Residual tumor | W | p |
---|---|---|---|---|
A | ||||
0 | 4.25E-8 ± 3.71E-8 | 1.93E-8 ± 3.13E-8 | 30 | 0.025 |
1 | 1.83E-8 ± 1.24E-8 | 1.35E-8 ± 1.07E-8 | 12 | > 0.05 |
4 | 3.61E-8 ± 2.34E-8 | 1.98E-8 ± 1.37E-8 | 28 | <0.05 |
7 | 9.13E-8 ± 1.05E-7 | 3.04E-8 ± 2.7E-8 | 30 | 0.025 |
β | ||||
0 | 0.91 ± 0.41 | 0.62 ± 0.37 | 16 | >0.05 |
1 | 1.01 ± 0.51 | 0.62 ± 0.22 | 22 | >0.05 |
4 | 0.97 ± 0.67 | 0.81 ± 0.25 | 12 | >0.05 |
7 | 1.46 ± 0.58 | 0.82 ± 0.59 | 26 | 0.05 |
Aβ | ||||
0 | 4.13E-8 ± 4.03E-8 | 1.54E-8 ± 2.81E-8 | 24 | >0.05 |
1 | 2.16E-8 ± 2.19E-8 | 9.63E-9 ± 9.88E-9 | 10 | >0.05 |
4 | 3.14E-8 ± 3.06E-8 | 1.61E-8 ± 1.19E-8 | 10 | >0.05 |
7 | 1.35E-7 ± 1.72E-7 | 2.94E-8 ± 3.11E-8 | 32 | <0.025 |
Wilcoxon Signed-Rank test, one-tail.